Login
$KARD
$13.60 +$0.97 (7.68%) Close

$KARD 4 SEC Filings

Filed On Filing
01 Oct 2026 Form 4: Reinke Kristin Marie K, Director

Granted 48,368 Stock Options (right to buy)

13 Jul 2026 Form 4: Perceptive Advisors Llc, Director and 3 others

Received 20,706 shares as a grant or award

24 Jun 2026 Form 4: Hrtg GPE, Llc, 10% owner and 4 others

Bought 3,125,000 shares ($50M)

24 Jun 2026 Form 4: Berns Paul L, Director

Bought 1,250,000 shares ($20M)

24 Jun 2026 Form 4: Arch Venture Partners XIII, Llc, Director and 6 others

Bought 1,250,000 shares ($20M)

22 Jun 2026 Form 4: Hrtg GPE, Llc, 10% owner and 4 others

Received 13,792,034 shares by conversion

22 Jun 2026 Form 4: Arch Venture Partners XIII, Llc, Director and 6 others

Received 13,792,035 shares by conversion

22 Jun 2026 Form 4: Pasternak Andy, Chief Strategy Officer

Received 79,640 shares as a grant or award

22 Jun 2026 Form 4: Meeker David P, Director

Received 20,706 shares as a grant or award

22 Jun 2026 Form 4: Berns Paul L, Director

Received 13,792,035 shares by conversion · Received 20,706 shares as a grant or award

22 Jun 2026 Form 4: Moriarty John B, Chief Legal Officer

Received 47,784 shares as a grant or award

22 Jun 2026 Form 4: Jahn Brianne, Chief Financial Officer

Received 79,640 shares as a grant or award

22 Jun 2026 Form 4: Popovits Kimberly J, Director

Received 20,706 shares as a grant or award

22 Jun 2026 Form 4: Walbert Timothy P, Director

Received 20,706 shares as a grant or award · Granted 57,573 Stock Option (Right to Buy)

22 Jun 2026 Form 4: Gianakakos Anastasios, Director

Received 568,395 shares by conversion

22 Jun 2026 Form 4: Giordano Douglas E., Director

Received 20,706 shares as a grant or award

22 Jun 2026 Form 4: Edelberg Jay, Chief Medical Officer

Received 97,587 shares by conversion · Received 47,784 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support